These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 15131518

  • 21. Predictors of longitudinal outcomes after unstable response to acute-phase cognitive therapy for major depressive disorder.
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    Psychotherapy (Chic); 2015 Jun; 52(2):268-77. PubMed ID: 25985046
    [Abstract] [Full Text] [Related]

  • 22. Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial.
    Kocsis JH, Gelenberg AJ, Rothbaum BO, Klein DN, Trivedi MH, Manber R, Keller MB, Leon AC, Wisniewski SR, Arnow BA, Markowitz JC, Thase ME, REVAMP Investigators.
    Arch Gen Psychiatry; 2009 Nov; 66(11):1178-88. PubMed ID: 19884606
    [Abstract] [Full Text] [Related]

  • 23. Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression.
    Feiger AD, Bielski RJ, Bremner J, Heiser JF, Trivedi M, Wilcox CS, Roberts DL, Kensler TT, McQuade RD, Kaplita SB, Archibald DG.
    Int Clin Psychopharmacol; 1999 Jan; 14(1):19-28. PubMed ID: 10221638
    [Abstract] [Full Text] [Related]

  • 24. Cognitive-behavioral analysis system of psychotherapy as a maintenance treatment for chronic depression.
    Klein DN, Santiago NJ, Vivian D, Blalock JA, Kocsis JH, Markowitz JC, McCullough JP, Rush AJ, Trivedi MH, Arnow BA, Dunner DL, Manber R, Rothbaum B, Thase ME, Keitner GI, Miller IW, Keller MB.
    J Consult Clin Psychol; 2004 Aug; 72(4):681-8. PubMed ID: 15301653
    [Abstract] [Full Text] [Related]

  • 25. REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design.
    Trivedi MH, Kocsis JH, Thase ME, Morris DW, Wisniewski SR, Leon AC, Gelenberg AJ, Klein DN, Niederehe G, Schatzberg AF, Ninan PT, Keller MB.
    Psychopharmacol Bull; 2008 Aug; 41(4):5-33. PubMed ID: 19015627
    [Abstract] [Full Text] [Related]

  • 26. Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial.
    Roy-Byrne PP, Pages KP, Russo JE, Jaffe C, Blume AW, Kingsley E, Cowley DS, Ries RK.
    J Clin Psychopharmacol; 2000 Apr; 20(2):129-36. PubMed ID: 10770449
    [Abstract] [Full Text] [Related]

  • 27. Effect of Disorder-Specific vs Nonspecific Psychotherapy for Chronic Depression: A Randomized Clinical Trial.
    Schramm E, Kriston L, Zobel I, Bailer J, Wambach K, Backenstrass M, Klein JP, Schoepf D, Schnell K, Gumz A, Bausch P, Fangmeier T, Meister R, Berger M, Hautzinger M, Härter M.
    JAMA Psychiatry; 2017 Mar 01; 74(3):233-242. PubMed ID: 28146251
    [Abstract] [Full Text] [Related]

  • 28. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.
    Nemeroff CB, Heim CM, Thase ME, Klein DN, Rush AJ, Schatzberg AF, Ninan PT, McCullough JP, Weiss PM, Dunner DL, Rothbaum BO, Kornstein S, Keitner G, Keller MB.
    Proc Natl Acad Sci U S A; 2003 Nov 25; 100(24):14293-6. PubMed ID: 14615578
    [Abstract] [Full Text] [Related]

  • 29. Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder.
    Perlis RH, Nierenberg AA, Alpert JE, Pava J, Matthews JD, Buchin J, Sickinger AH, Fava M.
    J Clin Psychopharmacol; 2002 Oct 25; 22(5):474-80. PubMed ID: 12352270
    [Abstract] [Full Text] [Related]

  • 30. Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy.
    Rohde P, Silva SG, Tonev ST, Kennard BD, Vitiello B, Kratochvil CJ, Reinecke MA, Curry JF, Simons AD, March JS.
    Arch Gen Psychiatry; 2008 Apr 25; 65(4):447-55. PubMed ID: 18391133
    [Abstract] [Full Text] [Related]

  • 31. Differential effects of treatments for chronic depression: a latent growth model reanalysis.
    Stulz N, Thase ME, Klein DN, Manber R, Crits-Christoph P.
    J Consult Clin Psychol; 2010 Jun 25; 78(3):409-19. PubMed ID: 20515216
    [Abstract] [Full Text] [Related]

  • 32. Dysfunctional attitudes and personality disorder comorbidity during long-term treatment of MDD.
    Farabaugh A, Mischoulon D, Schwartz F, Pender M, Fava M, Alpert J.
    Depress Anxiety; 2007 Jun 25; 24(6):433-9. PubMed ID: 17086540
    [Abstract] [Full Text] [Related]

  • 33. Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.
    Jarrett RB, Thase ME.
    Contemp Clin Trials; 2010 Jul 25; 31(4):355-77. PubMed ID: 20451668
    [Abstract] [Full Text] [Related]

  • 34. A 9-week randomized trial comparing a chronotherapeutic intervention (wake and light therapy) to exercise in major depressive disorder patients treated with duloxetine.
    Martiny K, Refsgaard E, Lund V, Lunde M, Sørensen L, Thougaard B, Lindberg L, Bech P.
    J Clin Psychiatry; 2012 Sep 25; 73(9):1234-42. PubMed ID: 23059149
    [Abstract] [Full Text] [Related]

  • 35. Initial Steps to inform selection of continuation cognitive therapy or fluoxetine for higher risk responders to cognitive therapy for recurrent major depressive disorder.
    Vittengl JR, Anna Clark L, Thase ME, Jarrett RB.
    Psychiatry Res; 2017 Jul 25; 253():174-181. PubMed ID: 28388454
    [Abstract] [Full Text] [Related]

  • 36. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.
    Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Dunlop BW, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen R, Yan B, Ahmed S, Schmidt M, Ninan PT.
    Biol Psychiatry; 2007 Dec 15; 62(12):1371-9. PubMed ID: 17825800
    [Abstract] [Full Text] [Related]

  • 37. New strategies for treating chronic depression.
    Kocsis JH.
    J Clin Psychiatry; 2000 Dec 15; 61 Suppl 11():42-5. PubMed ID: 10926054
    [Abstract] [Full Text] [Related]

  • 38. Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder.
    Kennard BD, Emslie GJ, Mayes TL, Nightingale-Teresi J, Nakonezny PA, Hughes JL, Jones JM, Tao R, Stewart SM, Jarrett RB.
    J Am Acad Child Adolesc Psychiatry; 2008 Dec 15; 47(12):1395-404. PubMed ID: 18978634
    [Abstract] [Full Text] [Related]

  • 39. Systematic reviews of randomised clinical trials examining the effects of psychotherapeutic interventions versus "no intervention" for acute major depressive disorder and a randomised trial examining the effects of "third wave" cognitive therapy versus mentalization-based treatment for acute major depressive disorder.
    Jakobsen JC.
    Dan Med J; 2014 Oct 15; 61(10):B4942. PubMed ID: 25283628
    [Abstract] [Full Text] [Related]

  • 40. Stable remission and recovery after acute-phase cognitive therapy for recurrent major depressive disorder.
    Vittengl JR, Clark LA, Thase ME, Jarrett RB.
    J Consult Clin Psychol; 2014 Dec 15; 82(6):1049-59. PubMed ID: 25045908
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.